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A new adenosine analogue adenosine 5’-(2-bromo- 
ethyl)-phosphate has been synthesized. The reactive 
moiety, a bromoalkyl group, has the  ability to react 
with  the  nucleophilic  side  chains of several amino acids. 
This compound reacts  with NAD-dependent  isocitrate 
dehydrogenase from pig heart, causing inactivation. 
Addition of the  allosteric  regulator ADP to  the  reaction 
mixture  protects  the  enzyme  from loss of activity. A 
second  adenosine  analogue has been  synthesized,  aden- 
osine 6’-(n-propyl)-phosphate,  which is used to assess 
any  effects  that  might  arise from the  noncovalent in- 
teraction of adenosine S’-(Z-bromoethyl)-phosphate 
with  the  enzyme.  It is proposed  that  adenosine 6’-(2- 
bromoethy1)-phosphate reacts  with an adenine  nucleo- 
tide site on isocitrate  dehydrogenase  and  that  this  com- 
pound may have general applicability as an affinity 
label of catalytic and regulatory adenine nucleotide 
sites in proteins. 
Purine nucleotides, particularly adenine nucleotides, act as 
coenzymes and regulators in a wide variety of biochemical 
reactions. In fact, regulation by adenine nucleotides is so 
prevalent that Atkinson and Walton proposed the adenylate 
control hypothesis, stating that energy metabolism is sensi- 
tively controlled by the varying distribution among AMP, 
ADP, and  ATP of the  total adenylate pool (1). One approach 
to probing the structure of the purine nucleotide sites of 
proteins is to use nucleotide analogues which simulate the 
natural coenzyme or effector, but which have reactive func- 
tional groups at particular positions of the purine or ribose 
ring. Several such purine nucleotide analogues have been 
synthesized. Colman et al. (2) and  Pal et al. (3) have described 
the synthesis and applications of a class of purine nucleotide 
analogues carryingp-fluorosulfonylbenzoyl groups. One of the 
most useful of these derivatives has been 5”pfluorosulfonyl- 
benzoyl adenosine, which has been found to chemically  modify 
a variety of proteins including glutamate dehydrogenase (4),  
malate dehydrogenase (5), RNA polymerase (6)’ pyruvate 
kinase (7), phosphofructokinase (8,9), cyclic AMP-dependent 
protein kinase (10,  ll), mitochondrial F1 ATPase (12), and an 
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ADP binding protein of human platelet membranes (13). 
Hampton (14) has described a number of purine nucleotide 
analogues such as N‘-p-fluorobenzoyl adenosine phosphates, 
6-chloropurine ribose phosphates, and carboxylic-phosphoric 
anhydrides of adenine nucleotides. Experience with these and 
other analogues has been reviewed (15). Despite the effective- 
ness of some of these analogues, their use entails certain 
disadvantages. The compounds may be relatively water insol- 
uble like the p-fluorosulfonylbenzoyl adenosines; they may be 
very unstable like carboxylic-phosphoric anhydrides of nu- 
cleosides; they may cany bulky groups which may weaken 
the prior binding of the reagent; or the reactive group may be 
at a region where major classes of enzymes using adenine 
nucleotides are  not expected to have catalytically significant 
functional groups. We have synthesized an adenosine ana- 
logue, adenosine 5”(2-bromoethyl)-phosphate, which is water- 
soluble, is sterically very similar to adenosine diphosphate, 
has a negative charge at  neutral pH, and is stable over a wide 
range of pH and buffer conditions. In addition, the bromoalkyl 
group is capable of reaction with most nucleophilic groups in 
proteins and is Iocated at  a position  where phosphotransferase, 
pyrophosphotransferase, and nucleotidyltransferase enzymes 
may  be expected to have catalytically important amino acid 
residues. In this paper, we present evidence  suggesting that 
adenosine 5‘-(2-bromoethyl)-phosphate reacts covalently at  
an adenine nucleotide site of the NAD-dependent isocitrate 
dehydrogenase from pig heart. 
EXPERIMENTAL PROCEDURES 
Materiakr-Bromoethanol was purchased from Aldrich Chemical 
Co., but was purified prior to use in the synthesis of 5”BrEtAMP.l 
To 100 g of bromoethanol, anhydrous sodium carbonate was added 
until the suspension was neutral to  pH paper. Anhydrous sodium 
sulfate (14 g) was then added and the whole suspension was  allowed 
to stand overnight before being filtered. Several grams of Drierite (W. 
A. Hammond Drierite Co.) were added to  the filtrate  and the suspen- 
sion was allowed to  stand for several hours in a dry place. The mixture 
was filtered again and the filtrate was distilled under reduced pressure. 
Only those fractions distilling at  5940°C were collected and  stored 
over dry nitrogen. Pyridine was distilled over NaOH and  stored over 
4-A molecular sieves. NAD-dependent isocitrate dehydrogenase was 
prepared according to Ramachandran and Colman (16). Enzyme was 
dialyzed against 0.05 M 1,4-piperazinediethanesulfonic acid buffer, pH 
7.0, containing 2 m~ MnSOl and 20% glycerol, before use. For native 
enzyme, the protein comentration was determined by multiplying the 
absorbance at 280 nm by  1.55 (17). 
Isocitrate, ADP, NAD, 5’-adenosine phosphomorpholidate, and 
snake venom phosphodiesterase were all obtained from Sigma Chem- 
ical Co. Dioxane/HCl was purchased from Pierce Chemical Co. 
Preparation  oftlderwsine 5’-(2-BromoethyZ)-phosphate-One mil- 
limole of 5”adenosine phoaphomorpholidate was dissolved in 25 ml of 
dry pyridine and was evaporated to dryness. This procedure was 
repeated three times, after which 25 ml of dry pyridine were added, 
followed by 3.5 ml ( 5 0  mmol) of 2-bromoethanol and 0.25 ml of 4 N 
dioxane/HCl. The mixture was  allowed to  stand overnight and 25 ml 
of water were added to  the reaction mixture. The solvent was evap- 
orated in vacuo to a glassy residue. To precipitate the solid, 100 ml of 
ethanolacetone (1:l) were added. The precipitate containing crude 
5”BrEtAMP was collected, redissolved in water, and concentrated. 
To purify the 5’-BrEtAMP, the concentrate was applied to a 
column (1.5 X 24 cm) of the hydrogen form of AG50-X8 (Bio-Rad 
Laboratories) and was eluted with water. The fractions were examined 
‘The abbreviations used are: 5’-BrEtAMP, adenosine 5“(2-bro- 
moethy1)-phosphate; and 5’-n-PrAMP, adenosine B’-(n-propyl)-phos- 
phate. 
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by thin layer chromatography, as described under “Results.” The 
major ultraviolet-absorbing peak occurred at 225 ml, and  fractions 
eluting  between 100 and  325 ml were  found to  contain  chromatograph- 
ically homogeneous 5”BrEtAMP. These fractions were pooled, ti- 
trated to  neutrality with  NaOH,  and evaporated  to  dryness.  (Samples 
used  for elemental  analysis  were  not  neutralized  prior  to  evaporation.) 
Approximately 0.21 m o l  of 5”BrEtAMP were recovered in this 
peak.  Fractions  eluting  after 400 ml contained  5’-AMP as the  major 
product. 
Determination of Bromide  Content of 5‘-BrEtAh@-BrEtAMp 
was  hydrolyzed by 0.6 M NaOH  in a boiling  water bath for 2 h, after 
which the solution  was  neutralized by the addition of glacial  acetic 
acid.  The  bromide  which  was  released  was  measured  using a Beckman 
pH  meter  equipped  with a bromide electrode  and  standard  bromide 
solutions  containing the same salt concentration as the sample. 
Preparation of Adenosine 5’-(n-Propyl)-phosphate-One milli- 
mole of 5’-AMP, 2H20(2H”) was dissolved in 250 ml of n-propyl 
alcohol  and 2 m o l  of triethylamine were  added.  Dicyclohexylcar- 
bodiimide (5 mmol)  was  added  and the mixture  was stirred for 72 h, 
a time  period  sufficient to allow  almost  complete  conversion of the 5” 
AMP to product, as judged by thin layer chromatography. The 
solvent  was  evaporated  in U ~ C U O  and the residue  was  dissolved  in  25 
ml of water. The insoluble  dicyclohexylurea  was  removed  by filtration 
and the filtrate was extracted twice  with  15 ml of ether. The aqueous 
solution was adjusted  to  neutrality  with  NaOH  and was evaporated 
to  dryness. 
Enzyme  Assay-Isocitrate  dehydrogenase  activity  was  determined 
at 25°C in Tris, 0.033 M acetate buffer, pH 7.2, by measuring the 
increasing  absorbance of  NADH at 340 nm  using a Gilford  model  240 
spectrophotometer  equipped  with  an  expanded  scale  recorder (0 to 
0.1 absorbance full scale). The substrate concentrations used  were  20 
mM isocitrate, 1 m~ NAD’, and 1.33 m~ MnSOa  in a total volume of 
1.0 ml. 
Kinetics of Reaction of 5‘-BrEtAMP with NAD-dependent Isocit- 
rate Dehydrogenase-Isocitrate dehydrogenase (0.217 mg/ml) was 
incubated at 25°C  in 0.1 M triethanolamine acetate, pH 8.0, containing 
20%  glycerol, 5 m~ magnesium sulfate,  and 125 FM EDTA for 90 min, 
after which the nucleotide analogues were added to initiate the 
reaction.  When  ADP  was present,  it was  added after the preincubation 
period.  During the course of reaction of isocitrate  dehydrogenase  with 
5’-BrEtAMP, aliquots were withdrawn at given time intervals and 
assayed by the procedure described above. Since the reagent was 
diluted  approximately  200-fold in the assay  solution,  it was considered 
that essentially no reaction  between  5”BrEtAMP  and  isocitrate  de- 
hydrogenase took place during the l- to 2-min period required to 
conduct the assay.  Indeed, the individual  assays  were  linear  and the 
measured rates were  assumed to  reflect the residual  enzymatic activ- 
ity at the time of withdrawal of aliquots from the reaction  mixture. 
RESULTS AND DISCUSSION 
Characterization of Adenosine 5‘-(2-BromoethyZ)-phos- 
phate-The  purity of the  compound synthesized was assessed 
by high pressure liquid chromatography  and  thin  layer  chro- 
matography with several solvent systems. Using a Varian 
model 5000 high pressure liquid chromatograph,  the  sample 
was chromatographed  on a reverse phase column (MCH-LO, 
300 X 4 mm) using 0.1 M triethylammonium  acetate,  pH 6.9, 
20% methanol (flow rate 2.0 ml/min)  as mobile phase. A single 
peak was observed with a retention time of 9.9 min. Thin 
layer chromatography was  performed on cellulose-coated  alu- 
minum  plates  (Brinkmann, 0.1-mm thickness) using the fol- 
lowing solvent systems: 1) ethanol, 1 M ammonium  acetate, 
0.5 M trichloroacetic acid (60:30:10); 2) acetonitrile, 2 M lithium 
chloride, water (70:15:15); 3) methyl ethyl ketone, acetone, 
water (65:20:15); and  4) t-amyl  alcohol, 88% formic acid,  water 
(404020).  In all four cases, a single ultraviolet  absorbing  spot 
was observed,  exhibiting RF values of 0.66,0.66,0.34, and 0.88 
in solvents 1, 2, 3, and 4, respectively. For comparison, 5’- 
AMP  exhibits RF values of 0.40,0.15,0.07, and 0.58 in solvents 
1, 2, 3, and 4, respectively. 
The  5”BrEtAMP  has been demonstrated  to  have  the  struc- 
ture shown  in Fig. 1 on  the basis of the  ultraviolet  absorption 
spectrum,  elemental analysis,  digestion  with phosphodiester- 
II I 
OH OH 
Adenosine 5’- ( 2-Bromoethyl ) - Phosphote 
0 
II 
I CH3-(-~2-  CH2 - 0 Ip- 0 - 
OH d 
OH OH 
Adenosine 5’- ( n - Propyl 1 - Phosphate 
FIG. 1. Structures of adenine nucleotide  analogues. 
ase,  and 13C and ‘H NMR spectra.  The  ultraviolet  absorption 
spectrum  exhibits a  maximum at 259 nm and  minimum at 227 
nm when measured in water at pH 7. The 250:260 and 280:260 
ratios along  with  maxima and  minima at different values of 
pH  are  almost  identical  with  those of 5’-AMP. 
The  elemental analysis is in agreement with the  structure 
given in Fig.  1, assuming that 1 water molecule is associated 
with the compound. 
C12NaOaHlsPIBrt 
Calculated:  30.53C  14.83N  4.03H 
Found 30.98C 13.82N  4.01H 
Phosphate was determined by the  method of Fiske and  Sub- 
barow  (described  in Ref. 18). The ratio of phosphate to 
spectrophotometrically determined adenosine was 1.01:l.OO. 
The  bromide  content was measured  after hydrolysis  in 0.6 N 
NaOH, as described under  “Experimental Procedures.” The 
ratio of Br- to spectrophotometrically  determined  adenosine 
was 1.06:l.OO. Upon digestion with  snake venom phosphodi- 
esterase,  5”BrEtAMP yielded  a  single ultraviolet  absorbing 
material having RF values  identical  with  those of 5’-AMP in 
the four solvent  systems described  above. 
All  I3C NMR spectra were obtained using a Bruker HFX- 
90. Proton-decoupled 13C NMR spectra were measured in 50% 
deuterium oxide and  the resonance peaks were assigned by 
comparison with  those of standard adenosine phosphates (19) 
and  2-bromoethanol.  The  resonance  peaks were  assigned as 
follows: C6 a t  155.6 ppm, C2 at 152.9 ppm, C4 at  150.2 ppm, CR 
at 139.9 ppm, C5 at 118.8 ppm, CY at 87.4 ppm, cq. at 84.1 ppm 
(doublet), Cp. at 74.4 ppm, Cs. at 70.9 ppm, CS at 65.9 ppm, CI 
of the  bromoethanol  moiety a t  65.9 ppm, C2 of the bromo- 
ethanol moiety at 31.6 ppm (doublet). The phosphodiester 
nature and the proposed structure was also evident from 
coupling constants of phosphorus  and  carbon observed in  the 
spectrum.  The fine structures of P-0-C peaks were not  ob- 
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FIG. 2. Reaction of adenosine nucleotide analogues with 
NAD-dependent isocitrate dehydrogenase from pig heart. Iso- 
citrate dehydrogenase (0.217 mg/ml) was incubated with the nucleo- 
tide analogues at 25°C in 0.1 M triethanolamine acetate buffer, pH 
8.0, containing 20% glycerol, 5 m~ magnesium sulfate, and 125 IM 
EDTA. At each indicated time, an aliquot was withdrawn  and assayed 
as described under  "Experimental Procedures." A, 12 m~ 5'-Br- 
EtAMP added; B, same as (A)  + 9.4 mM ADP added to the reaction 
mixture; C, 16.0 m~ 5"n-PrAMP added. 
served, which is consistent with the general experience that 
P-0-C coupling constants  are generally smaller than  P-0-C-C 
coupling constants in cases of 5"nucleotides (19). 
All proton NMR spectra were measured in a Perkin-Elmer 
R-12  (60 MHz). The spectrum contains two clearly resolvable 
peaks at 68.30 and 88.05, which are assigned to HB and Hn 
protons, and  another clearly resolved doublet at 66.0,  which is 
assigned to  HI,.  The rest of the spectrum is Consistent  with 
the  structure shown  in  Fig. 1. 
Characterization of 5'-(n-Propyl) Adenosine Monophos- 
phate-The purity of the compound was assessed by thin 
layer chromatography on cellulose using the four solvent 
systems described above. The ultraviolet absorption spectra 
at different pH  values are remarkably similar to those of 5'- 
BrEtAMP and 5'-AMP spectra, as expected. 
The proton NMR spectrum, measured in deuterium oxide, 
gave peaks which are assigned as follows: HZ or Hn, 68.30; H2 
or Ha, 88.05; H1,, 66.00 (doublet); H2', H3,, H4,, and Hs, com- 
bined multiplets, and HDO, 64.00 to 4.50, HI of propanol, 
multiplet centered at 83.6; HZ of propanol, multiplet centered 
at  61.45; HB of propanol, triplet centered at 80.65. 
Reaction of 5"BrEtAMP with NAD-dependent Isocitrute 
Dehydrogenase from Pig Heart-The pig heart NAD-de- 
pendent isocitrate dehydrogenase is an allosteric enzyme 
which is activated by ADP (20). The enzyme has been  shown 
to bind both NAD and ADP (21) and thus was expected to be 
a good candidate for affinity labeling by the adenine nucleo- 
tide analogue, 5"(2-bromoethyl) adenosine monophosphate. 
Incubation of the NAD-dependent isocitrate dehydrogenase 
with 5"BrEtAMP in 0.1 M triethanolamine acetate,  pH 8.0, 
containing 5 mM magnesium sulfate, 20% glycerol, and 125 
~ U M  EDTA, results in a progressive  loss of isocitrate dehydro- 
genase activity, as shown  in  Fig. 2, line A .  The time-dependent 
inactivation follows pseudo-first order kinetics as f a r  as about 
15%  of initial activity, yielding a  rate constant of 0.0092 min" 
(an average of several determinations) at a 5"BrEtAMP con- 
centration of 12 mM. 
The rate constant for inactivation of isocitrate dehydro- 
genase  was measured over the concentration range of 4 to 60 
mM 5'-BrEtAMP, revealing a nonlinear dependence of the 
rate constant on the reagent concentration. These  data  are 
consistent with a mechanism in which 5"BrEtAMP binds 
reversibly to  the enzyme ( K d  = 50 m ~ )  prior to  the irreversible 
inactivation. Such kinetic behavior is normally  expected  for 
an affinity label. 
In order to evaluate the contribution of the AMP moiety to 
the effectiveness of 5"BrEtAMP in inactivating isocitrate 
dehydrogenase, the effect of 2-bromoethanol on the enzyme 
was tested. Isocitrate dehydrogenase, upon incubation with 36 
mM 2-bromoethanol under the same conditions as those of 
Fig. 2, was very slowly inactivated. The reaction obeyed 
pseudo-first order kinetics with an observed rate constant of 
O.OOO64 min", yielding a calculated second order rate constant 
for the 2-bromoethanol reaction of  0.018  min" M". Thus, at 
12 mM 2-bromoethanol, the  rate for inactivation would  be I/qg 
that observed for 5"BrEtAMP at  the same concentration. 
To assess the possibility that inactivation by 5"BrEtAMP 
resulted from a destabilization of the enzyme by noncovalent 
binding of this compound, the effect on the enzyme of incu- 
bation with the nonreactive 5'-(n-propyl) AMP was tested. 
Fig. 2, line C shows that 5l-n-PrAMP does not inactivate the 
enzyme, thus implying it is the bromoalkyl group that is 
responsible for the inactivation caused by that reagent. 
Specificity of a protein chemical modification reaction can 
be indicated by the ability of a particular ligand to markedly 
reduce the reaction rate of the enzyme  with the reagent, Fig. 
2, line  B demonstrates that  the inclusion of 9.4 n" ADP in 
the reaction mixture completely abolishes the inactivation, 
suggesting that  the ADP site may be the site of attack by 5'- 
BrEtAMP. 
The importance of the adenosine moiety in the reaction, 
the specific protection offered by the allosteric effector ADP, 
and the inability of adenosine 5'-(n-propyl)-phosphate to in- 
activate the enzyme all indicate that 5"BrEtAMP may be 
acting as  an  affiity label of an adenine nucleotide site in the 
NAD-specific isocitrate dehydrogenase. It is proposed that 
adenosine 5'-(2-bromoethyl)-phosphate may have general ap- 
plicability as  an affinity label for proteins which have either 
catalytic or regulatory adenine nucleotide binding sites. 
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